Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1527
-
Total 13F shares, excl. options
-
969M
-
Shares change
-
-3.01M
-
Total reported value, excl. options
-
$56.4B
-
Value change
-
-$213M
-
Put/Call ratio
-
1.21
-
Number of buys
-
607
-
Number of sells
-
-826
-
Price
-
$58.26
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2020
1,773 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2020.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,527 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 969M shares
of 1.24B outstanding shares and own 78.11% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (122M shares), BlackRock Inc. (111M shares), VANGUARD GROUP INC (103M shares), STATE STREET CORP (55.2M shares), Capital International Investors (46.5M shares), Capital World Investors (38.5M shares), GEODE CAPITAL MANAGEMENT, LLC (20.1M shares), Dodge & Cox (17.1M shares), NORTHERN TRUST CORP (15.2M shares), and Bank of New York Mellon Corp (13.8M shares).
This table shows the top 1527 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.